INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 434m ago
HOUSE PTR34m ago
SEC 13F34m ago
ROBINHOOD CHAIN34m ago
Public company

Definium Therapeutics, Inc.

DFTXCIK 0001813814

EDGAR filingsOpen in network
Price$33.27
1 year+188.6%
Disclosed transactions0
Buys / sells0 / 0
Max Insider Score—
Connections with evidence2

DFTX · disclosed activity on price

Disclosed transactions

No records

No transactions recorded for this profile.

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2833 · Medicinal Chemicals & Botanical Products · Nov 4, 2026
  • ← Holds over 5% ofevidence
    FMR LLC6.5% of class · Schedule 13G · Nov 4, 2026

Planned sales and 5% stakes

Form 144, 13D and 13G
  • FMFMR LLCPassive holder · crossed on Sep 30, 2026 · 8.79M shares6.5% of class13G · filed Nov 5, 2026